Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture

BACKGROUND: Angiogenesis inhibitors (AIs) combination with cytotoxic chemotherapy is a promising treatment for patients with colorectal cancer (CRC). Aflibercept (AFL) is an option for second-line treatment of CRC, according to the ‘VELOUR’ trial. Currently, we can choose from three AIs, including b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Taichi, Takahashi, Kentaro, Shibuya, Kengo, Muto, Osamu, Yoshida, Yuko, Taguchi, Daiki, Shimazu, Kazuhiro, Fukuda, Koji, Ono, Fuminori, Nomura, Kyoko, Shibata, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040061/
https://www.ncbi.nlm.nih.gov/pubmed/33889280
http://dx.doi.org/10.4251/wjgo.v13.i4.295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040061/
https://www.ncbi.nlm.nih.gov/pubmed/33889280
http://dx.doi.org/10.4251/wjgo.v13.i4.295

Ejemplares similares